Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities. Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril…
The post Drugs facing the most…
Drugs facing the most patent expirations this year Read Post »
Annual Drug Patent Expirations for ARNUITY+ELLIPTA Arnuity Ellipta is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from one supplier. There are six patents…
The post New patent for Glaxosmithkline drug ARNUITY ELLIPTA …
New patent for Glaxosmithkline drug ARNUITY ELLIPTA Read Post »
This chart shows the pharmaceutical companies with the most solution dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most solution dosed drugs…
The post Which pharmaceutical companies have the most so…
Which pharmaceutical companies have the most solution dosed drugs? Read Post »
Annual Drug Patent Expirations for ANGIOMAX+RTU Angiomax Rtu is a drug marketed by Maia Pharms Inc and is included in one NDA. It is available from three suppliers. The generic…
The post New patent for Maia Pharms drug ANGIOMAX RTU appeared first on Dr…
Annual Drug Patent Expirations for LEQVIO Leqvio is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are thirteen patents protecting…
The post New patent expiration for Novartis drug LEQVIO appeared first…
Annual Drug Patent Expirations for DALIRESP Daliresp is a drug marketed by Astrazeneca and is included in one NDA. It is available from one supplier. There are three patents protecting…
The post New patent expiration for Astrazeneca drug DALIRESP appea…
New patent expiration for Astrazeneca drug DALIRESP Read Post »
Annual Drug Patent Expirations for ULORIC Uloric is a drug marketed by Takeda Pharms Usa and is included in one NDA. It is available from one supplier. There are three…
The post New patent expiration for Takeda Pharms drug ULORIC appeared first on Drug…
New patent expiration for Takeda Pharms drug ULORIC Read Post »
Annual Drug Patent Expirations for GIVLAARI Givlaari is a drug marketed by Alnylam Pharms Inc and is included in one NDA. It is available from one supplier. There are twelve…
The post New patent expiration for Alnylam Pharms drug GIVLAARI appeared firs…
New patent expiration for Alnylam Pharms drug GIVLAARI Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Luxembourg. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
The post Which pharmaceuti…
Which pharmaceutical companies have the most SPCs in Luxembourg? Read Post »
Annual Drug Patent Expirations for MYCAPSSA Mycapssa is a drug marketed by Chiesi and is included in one NDA. It is available from two suppliers. There are eleven patents protecting…
The post New patent for Chiesi drug MYCAPSSA appeared first on DrugPa…